We are live on ! Find out more
GHCM

Glen Harbor Capital Management Portfolio holdings

AUM $4.82B
1-Year Est. Return 4.69%
This Fund
S&P 500
This Quarter Est. Return
+1%
1 Year Est. Return
+4.69%
3 Year Est. Return
+49.44%
5 Year Est. Return
10 Year Est. Return
AUM
$4.82B
AUM Growth
+$26.4M
Cap. Flow
+$13M
Cap. Flow %
0.27%
Top 10 Hldgs %
22.07%
Holding
1,377
New
54
Increased
479
Reduced
335
Closed
49

Top Sells

Rank Stock Value
1
CNC icon
Centene
CNC
+$22.4M
2
WFC icon
Wells Fargo
WFC
+$10.1M
3
FTNT icon
Fortinet
FTNT
+$10M
4
CTSH icon
Cognizant
CTSH
+$9.41M
5
BEN icon
Franklin Resources
BEN
+$9.26M

Sector Composition

Rank Sector Weight
1 Technology 17.48%
2 Financials 15.21%
3 Healthcare 11.87%
4 Consumer Discretionary 10.32%
5 Industrials 10.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NUAN
1301
DELISTED
Nuance Communications, Inc.
NUAN
$19K ﹤0.01%
1,321
-7,979
-86% -$115K
MEOH icon
1302
Methanex
MEOH
$4.3B
$18K ﹤0.01%
532
OBSV
1303
DELISTED
ObsEva SA Ordinary Shares
OBSV
$18K ﹤0.01%
2,142
AKRO
1304
DELISTED
Akero Therapeutics
AKRO
$17K ﹤0.01%
748
BB icon
1305
BlackBerry
BB
$4.98B
$17K ﹤0.01%
3,276
+28
+0.9% +$196
HRTX icon
1306
Heron Therapeutics
HRTX
$93.9M
$17K ﹤0.01%
946
BKU icon
1307
Bankunited
BKU
$3.37B
$16K ﹤0.01%
+464
New +$15.2K
CDNA icon
1308
CareDx
CDNA
$2.26B
$15K ﹤0.01%
+672
New +$18.6K
VRNT
1309
DELISTED
Verint Systems
VRNT
$15K ﹤0.01%
691
ALTR
1310
DELISTED
Altair Engineering Inc
ALTR
$15K ﹤0.01%
440
FATE icon
1311
Fate Therapeutics
FATE
$286M
$14K ﹤0.01%
896
PLAB icon
1312
Photronics
PLAB
$1.79B
$14K ﹤0.01%
+1,312
New +$12.7K
EZPW icon
1313
Ezcorp Inc
EZPW
$1.83B
$13K ﹤0.01%
+2,006
New +$17.2K
DNLI icon
1314
Denali Therapeutics
DNLI
$3.65B
$12K ﹤0.01%
756
IOVA icon
1315
Iovance Biotherapeutics
IOVA
$1.82B
$12K ﹤0.01%
640
-112
-15% -$2.48K
NTNX icon
1316
Nutanix
NTNX
$16B
$12K ﹤0.01%
462
UPLD icon
1317
Upland Software
UPLD
$12.8M
$11K ﹤0.01%
32
CSOD
1318
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$11K ﹤0.01%
208
NVTA
1319
DELISTED
Invitae Corporation
NVTA
$10K ﹤0.01%
+544
New +$12.8K
REPL icon
1320
Replimune Group
REPL
$941M
$9K ﹤0.01%
656
SSTI icon
1321
SoundThinking
SSTI
$100M
$9K ﹤0.01%
374
ALEC icon
1322
Alector
ALEC
$168M
$8K ﹤0.01%
560
VCIT icon
1323
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.2B
$8K ﹤0.01%
88
MIRM icon
1324
Mirum Pharmaceuticals
MIRM
$6.46B
$6K ﹤0.01%
+578
New +$7.09K
ESTC icon
1325
Elastic
ESTC
$6.84B
$5K ﹤0.01%
64

Similar funds

Glen Harbor Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Glen Harbor Capital Management held 1,377 positions worth $4.82B, up 0.55% from $4.79B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Glen Harbor Capital Management's Q3 2019 filing shows 54 new, 479 increased, 335 reduced and 49 closed positions. Its largest new stake was iShares Russell 2000 ETF: 119,680 shares worth $18.1M. The largest sale was Centene, an estimated $22.4M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

  • Glen Harbor Capital Management's largest Q3 2019 buy was iShares Russell 2000 ETF: 119,680 shares worth $18.1M.
  • Glen Harbor Capital Management added most to AT&T in Q3 2019, an estimated $13.4M increase.
  • Glen Harbor Capital Management's biggest Q3 2019 reduction was Centene, cutting an estimated $22.4M.
  • Glen Harbor Capital Management fully exited Vistance Networks Inc in Q3 2019, selling an estimated $1.62M.
  • Glen Harbor Capital Management's ten largest holdings make up 22% of its $4.82B portfolio in Q3 2019.
  • Glen Harbor Capital Management opened 54 new positions and closed 49 in Q3 2019.
  • Glen Harbor Capital Management's portfolio value rose 0.55% quarter-over-quarter to $4.82B.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.